Logo image of CTOR

CITIUS ONCOLOGY INC (CTOR) Stock Income Statement

NASDAQ:CTOR - Nasdaq - US17331Y1091 - Common Stock - Currency: USD

0.925  +0.04 (+3.93%)

After market: 0.955 +0.03 (+3.24%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2024
(2024-9-30)
Revenue
CTOR Revenue ChartCTOR Revenue over time chart
0.00
Operating Expenses
CTOR Operating Expenses ChartCTOR Operating Expenses over time chart
20.57M
Research and Development
CTOR Research and Development ChartCTOR Research and Development over time chart
4.92M
Selling, General, and Administrative Expenses
CTOR Selling, General, and Administrative Expenses ChartCTOR Selling, General, and Administrative Expenses over time chart
15.65M
Operating Income
CTOR Operating Income ChartCTOR Operating Income over time chart
-20.57M
Income Before Taxes
CTOR Income Before Taxes ChartCTOR Income Before Taxes over time chart
-20.57M
Income Tax
CTOR Income Tax ChartCTOR Income Tax over time chart
576.00K
Net Income
CTOR Net Income ChartCTOR Net Income over time chart
-21.15M
 
Per Share Data
EPS Diluted Total Ops
CTOR EPS Diluted Total Ops ChartCTOR EPS Diluted Total Ops over time chart
-0.31
 
Statistics

All data in USD

Charts

CTOR Income Statement data chartCTOR Revenue, Operating Income, Net Income and EBITDA ChartIncome Statements 2024 -5M -10M -15M -20M
CTOR Earnings Per Share (EPS) chartCTOR EPS Diluted and non-GAAP ChartEarnings Per Share 2024 0 0 0 0 0